Progress on the molecular anti-tumor mechanisms of arctigenin

doi:10.3969/j.issn.1673-8640.2016.06.022

Abstract

CLC Number:

R446.1

HUANG Dongdong, CAI Zhiyi. Progress on the molecular anti-tumor mechanisms of arctigenin[J]. Laboratory Medicine, 2016, 31(6): 546-548.

References 21

[1]	米靖宇,宋纯清. 牛蒡子中木脂素类化合物的抗肿瘤及免疫活性[J]. 时珍国医国药,2002,13(3):168-169.
[2]	TSAI WJ, CHANG CT, WANG GJ, et al.Arctigenin from Arctium lappa inhibits interleukin-2 and interferon gene expression in primary human T lymphocytes[J]. Chin Med,2011,6(1):12.
[3]	TANG X,ZHUANG J,CHEN J,et a1. Arctigenin efficiently enhanced sedentary mice treadmill endurance[J]. PLoS One,2011,6(8):e24224.
[4]	赵辉,袁莉,贾莉,等. 牛蒡子苷元对高糖刺激大鼠系膜细胞转化生长因子β1表达的影响[J]. 泰山医学院学报,2013,34(8):611-612.
[5]	GU Y,QI C,SUN X,et al.Arctigenin preferentially induces tumor cell death under glucose deprivation by inhibiting cellular energy metabolism[J].Biochem Pharmacol,2012,84(4):468-476.
[6]	KUDOU N,TANIGUCHI A,SUGIMOTO K,et al.Synthesis and antitumor evaluation of arctigenin derivatives based on antiausterity strategy[J]. Eur J Med Chem,2013,60:76-88.
[7]	TEZUKA Y,YAMAMOTO K,AWALE S,et al.Anti-austeric activity of phenolic constituents of seeds of Arctium lappa[J]. Nat Prod Commun, 2013,8(4):463-466.
[8]	AWALE S,KATO M,DIBWE DF,et al.Antiausterity activity of arctigenin enantiomers: importance of (2R,3R)-absolute configuration[J]. Nat Prod Commun,2014,9(1):79-82.
[9]	UMEHARA K,NAKAMURA M,MIYASE T,et al.Studies on differentiation inducers. Ⅵ. Lignan derivatives from Arctium fructus. (2)[J]. Chem Pharm Bull(Tokyo),1996,44(12):2300-2304.
[10]	SUSANTI S,IWASAKI H,INAFUKU M,et al.Mechanism of arctigenin-mediated specific cytotoxicity against human lung adenocarcinoma cell lines[J]. Phytomedicine,2013,21(1):39-46.
[11]	YANG S,MA J,XIAO J, et al.Arctigenin anti-tumor activity in bladder cancer T24 cell line through induction of cell-cycle arrest and apoptosis[J]. Anat Rec(Hoboken),2012,295(8):1260-1266.
[12]	KANG K,LEE HJ,YOO JH,et al.Cell and nuclear enlargement of SW480 cells induced by a plant lignan, arctigenin: evaluation of cellular DNA content using fluorescence microscopy and flow cytometry[J]. DNA Cell Biol,2011,30(8):623-629.
[13]	JEONG JB,HONG SC,JEONG HJ,et al.Arctigenin induces cell cycle arrest by blocking the phosphorylation of Rb via the modulation of cell cycle regulatory proteins in human gastric cancer cells[J]. Int Immunopharmacol,2011,11(10):1573-1577.
[14]	WYLLIE AH."Where,O death,is thy sting?" A brief review of apoptosis biology[J]. Mol Neurobiol,2010,42(1):4-9.
[15]	HSIEH CJ,KUO PL,HSU YC,et al.Arctigenin,a dietary phytoestrogen,induces apoptosis of estrogen receptor-negative breast cancer cells through the ROS/p38 MAPK pathway and epigenetic regulation[J]. Free Radic Biol Med, 2014 ,67:159-170.
[16]	YOO JH,LEE HJ,KANG K,et al.Lignans inhibit cell growth via regulation of Wnt/beta-catenin signaling[J]. Food Chem Toxicol,2010,48(8-9):2247-2252.
[17]	GU Y,SCHEUER C,FENG D,et al.Inhibition of angiogenesis: a novel antitumor mechanism of the herbal compound arctigenin[J]. Anticancer Drugs,2013,24(8):781-791.
[18]	WANG HQ,JIN JJ,WANG J.Arctigenin enhances chemosensitivity to cisplatin in human nonsmall lung cancer H460 cells through downregulation of survivin expression[J]. J Biochem Mol Toxicol,2014,28(1):39-45.
[19]	SUN S,WANG X,WANG C,et al.Arctigenin suppresses unfolded protein response and sensitizes glucose deprivation-mediated cytotoxicity of cancer cells[J]. Planta Med,2011,77(2):141-145.
[20]	朱孔梅. 牛蒡苷元联合替吉奥对H22荷瘤小鼠的抑瘤作用[J]. 山东医学高等专科学校学报,2013,35(5):333-335.
[21]	CHO JY,KIM AR,YOO ES,et al.Immunomodulatory effect of arctigenin, a lignan compound, on tumour necrosis factor-alpha and nitric oxide production, and lymphocyte proliferation[J]. J Pharm Pharmacol, 1999 ,51(11):1267-1273.

Progress on the molecular anti-tumor mechanisms of arctigenin

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 21

Related Articles 15

Recommended Articles

Metrics

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.